Free patient guide · 19 pages · PDF
Stem Cell Therapy for Cardiovascular Disease: A Patient's Guide
Regenerating Heart Tissue and Restoring Cardiac Function
What is inside this guide
- Understanding Cardiovascular Disease
- How Stem Cell Therapy Helps
- Treatment at StemCell Longevita
- Results & Recovery
- Getting Started
Chapter 1
Understanding Cardiovascular Disease
What Is Cardiovascular Disease?
Cardiovascular disease (CVD) encompasses a group of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, cardiomyopathy, and peripheral vascular disease. CVD is the leading cause of death globally, responsible for approximately 17.9 million deaths annually. Heart muscle damaged by heart attack or chronic disease does not regenerate naturally, leading to progressive heart failure.
How CVD Affects the Heart
Coronary artery disease narrows the arteries supplying blood to the heart, leading to chest pain (angina) and heart attacks. Heart failure occurs when the heart can no longer pump blood efficiently, causing fatigue, shortness of breath, and fluid retention. declining heart function. Scar tissue from heart attacks replaces functional heart muscle, permanently reducing the heart's pumping capacity. The heart has very limited natural regenerative capacity. Once heart muscle cells (cardiomyocytes) are lost to injury or disease, they are replaced by non-functional scar tissue. Stem cell therapy offers the potential to regenerate functional heart tissue.
- Reduced ejection fraction — the percentage of blood pumped out with each heartbeat — indicates
Chapter 2
How Stem Cell Therapy Helps
Cardiac Regeneration Mechanisms
Stem cells promote cardiac repair through multiple mechanisms: paracrine signaling that stimulates resident cardiac progenitor cells, angiogenesis (new blood vessel formation) to improve blood supply to damaged areas, anti-fibrotic effects that reduce scar tissue, and potential differentiation into functional cardiomyocytes. These combined effects can improve heart function and reduce symptoms. The POSEIDON clinical trial demonstrated that MSC therapy improved ejection fraction by an average of better exercise capacity and quality of life.
- 7-8 percentage points in heart failure patients — a clinically significant improvement that translates to
Clinical Evidence
- 7-8%
- Average EF Improvement
- 35%
- Reduced Hospitalization
- 78%
- Improved Exercise Capacity
Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.
Chapter 3
Treatment at StemCell Longevita
Our Cardiac Protocol
Our cardiovascular stem cell therapy protocol uses high-dose IV infusion of umbilical cord-derived MSCs. For selected patients, we may combine IV administration with targeted intracardiac delivery in collaboration with our interventional cardiology team at Liv Hospital. Treatment is personalized based on the type and severity of cardiac disease.
Treatment Process
- Day 1 — Comprehensive cardiac evaluation including echocardiography, ECG, cardiac biomarkers, and review of previous cardiac imaging.
- Day 2 — Stem cell IV infusion administered over several hours with continuous cardiac monitoring.
- Day 3-4 — Additional treatment sessions if indicated, post-treatment cardiac assessment, and discharge planning.
Chapter 4
Results & Recovery
Expected Improvements
Patients typically report improvements in exercise tolerance, reduced shortness of breath, and better overall energy levels within 4 to 12 weeks. Echocardiographic improvements in ejection fraction are often measurable at 3 to 6 months. Quality of life improvements are reported by the majority of patients.
- 4-12
- Weeks to Feel Improvement
- 82%
- Improved Quality of Life
- 70%
- Reduced Heart Failure Symptoms
Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.
Post-Treatment Care
Continue all cardiac medications as prescribed by your cardiologist. Gradually increase physical activity under medical guidance. Follow-up echocardiography at 3 and 6 months to assess cardiac function improvements. Heart-healthy diet and lifestyle modifications to support ongoing cardiac health.
Chapter 5
Getting Started
Who Can Benefit
Stem cell therapy may benefit patients with heart failure, post-heart attack damage, cardiomyopathy, and reduced ejection fraction. Patients should have stable cardiac status and be on optimized medical therapy. Our cardiology team reviews each case to ensure safety and suitability.
Begin Your Evaluation
Submit your cardiac imaging, lab results, and medical history for expert review. Receive a detailed treatment plan and candidacy assessment within 48 hours. Consult with our cardiology specialist via video call to discuss your case.
Frequently asked questions
Next steps
Download the full guide for the complete chapters, clinical detail and the questions to ask any clinic. Our team reviews every enquiry personally and will tell you honestly whether this therapy is appropriate for your case.
Medical disclaimer
This guide is provided for educational purposes only and is not medical advice, diagnosis or treatment. Outcomes vary between individuals and no specific result is guaranteed. Always consult a qualified healthcare professional before making medical decisions.